These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3978636)

  • 41. Pharmacokinetic and tumour-penetration properties of the hypoxic cell radiosensitizer desmethylmisonidazole (Ro 05-Ro-9963) in dogs.
    White RA; Workman P
    Br J Cancer; 1980 Feb; 41(2):268-76. PubMed ID: 7370166
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Polarographic measurement of misonidazole in mouse mammary tumors.
    Ohizumi Y; Maezawa H; Murayama C; Mori T
    Tokai J Exp Clin Med; 1984 Aug; 9(3):199-206. PubMed ID: 6537667
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biodistribution of 14C-misonidazole as a probe for hypoxic cells in a murine tumor model.
    Ikeda H; Takahashi I; Yonome I; Mitsuhashi N; Niibe H
    Anticancer Res; 1998; 18(1A):241-5. PubMed ID: 9568084
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Imaging experimental brain tumors with 1-aminocyclopentane carboxylic acid and alpha-aminoisobutyric acid: comparison to fluorodeoxyglucose and diethylenetriaminepentaacetic acid in morphologically defined tumor regions.
    Uehara H; Miyagawa T; Tjuvajev J; Joshi R; Beattie B; Oku T; Finn R; Blasberg R
    J Cereb Blood Flow Metab; 1997 Nov; 17(11):1239-53. PubMed ID: 9390656
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Misonidazole and other hypoxia markers: metabolism and applications.
    Franko AJ
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1195-202. PubMed ID: 3528089
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The penetration of misonidazole into a mature structural cartilage.
    Langler AJ; Bugden RD; Gibson P
    Br J Cancer; 1982 Feb; 45(2):282-5. PubMed ID: 7059476
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is misonidazole binding to mouse tissues a measure of cellular pO2?
    Van Os-Corby DJ; Koch CJ; Chapman JD
    Biochem Pharmacol; 1987 Oct; 36(20):3487-94. PubMed ID: 3675609
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Misonidazole binding in SCCVII tumors in relation to the tumor blood supply.
    Olive PL; Durand RE
    Int J Radiat Oncol Biol Phys; 1989 Mar; 16(3):755-61. PubMed ID: 2921174
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The metabolism and pharmacokinetics of the hypoxic cell radiosensitizer and cytotoxic agent, misonidazole, in C3H mice.
    Chin JB; Rauth AM
    Radiat Res; 1981 May; 86(2):341-57. PubMed ID: 7232696
    [No Abstract]   [Full Text] [Related]  

  • 50. Synthesis and in vivo studies of the radiosensitizer 4-[82Br]bromomisonidazole.
    Jette DC; Wiebe LI; Chapman JD
    Int J Nucl Med Biol; 1983; 10(4):205-10. PubMed ID: 6662623
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetics and toxicology of continuously infused nitroimidazoles.
    Eifel PJ; Brown JM
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1311-4. PubMed ID: 6236186
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In situ drug delivery.
    Levin VA; Wright DC; Landahl HD; Patlak CS; Csejtey J
    Br J Cancer Suppl; 1980 Apr; 4():74-8. PubMed ID: 6932949
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro metabolism of misonidazole.
    Josephy PD; Palcic B; Skarsgard LD
    Br J Cancer; 1981 Apr; 43(4):443-50. PubMed ID: 7236487
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A comparison of tumor and normal tissue levels of acidic, basic and neutral 2-nitroimidazole radiosensitizers in mice.
    Minchinton AI; Stratford MR
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1117-20. PubMed ID: 2943710
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Binding of misonidazole to hypoxic cells in monolayer and spheroid culture: evidence that a side-chain label is bound as efficiently as a ring label.
    Raleigh JA; Franko AJ; Koch CJ; Born JL
    Br J Cancer; 1985 Feb; 51(2):229-35. PubMed ID: 3966980
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Misonidazole retention by normal tissues: a distinction between label on the ring and side chain.
    Franko AJ; Garrecht BM
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1259-62. PubMed ID: 3744949
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sulphydryls, ascorbate and oxygen as modifiers of the toxicity and metabolism of misonidazole in vitro.
    Taylor YC; Rauth AM
    Br J Cancer; 1980 Jun; 41(6):892-900. PubMed ID: 7426314
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The pharmacokinetics in mice and dogs of nitroimidazole radiosensitizers and chemosensitizers more lipophilic than misonidazole.
    White R; Workman P; Owen L
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):473-6. PubMed ID: 7107369
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hypoxic fraction and binding of misonidazole in EMT6/Ed multicellular tumor spheroids.
    Franko AJ
    Radiat Res; 1985 Jul; 103(1):89-97. PubMed ID: 4070561
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Induced hypoxia in rat pulp and periapex demonstrated by 3H-misonidazole retention.
    Baumgardner KR; Walton RE; Osborne JW; Born JL
    J Dent Res; 1996 Oct; 75(10):1753-60. PubMed ID: 8955670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.